Expertise

Hyperthermia Cancer Treatment: HEATT® and Clinical Insights

April 24, 2023

Hyperthermia cancer treatment is a promising approach in the field of oncology, offering potential benefits for patients suffering from advanced-stage […]

Read More

Clinical Trial: Ovarian Cancer Overview

February 14, 2023

The Verthermia® team conducted an FDA Phase 1 clinical trial during 2014-2015, resulting in significant findings on the positive impact […]

Read More

Ovarian Cancer Trial Results: Cell Destruction

February 14, 2023

The image on the left shows the tumors at the beginning of the study. The image on the right shows […]

Read More

Ovarian Cancer Clinical Trial Results: Daily Living

February 14, 2023

Ovarian Cancer Trial Result: No Decline in Daily Activities P=0.643 N=24 Over 24 cycles of HEATT® the mean Karnofsky: Performance […]

Read More